Le Lézard
Classified in: Environment, Health, Science and technology
Subjects: RCY, CSR, ESG

GenScript upgrades product packaging with a recyclable strategy, reducing waste by 82% and contributing to environmental sustainability


PISCATAWAY, N.J., Jan. 14, 2025 /PRNewswire/ -- GenScript Biotech Corporation has unveiled an innovation in shipping packaging, propelling GenScript towards achieving their ambitious sustainability goals. The new packaging replaces plastic with 100% recyclable paper materials, reducing waste by 82% and lowering annual carbon emissions by 5.14 tons, equivalent to the CO2 absorbed by ~250 trees.

The redesigned packaging also eliminates foam, relying on paper's structural strength, which is recyclable, minimizing the carbon footprint and waste compared to foam. The ink used in the printing is water-based, which is biodegradable and non-toxic, reducing waste and ecological impact.

Sherry Shao, Rotating CEO said: "GenScript is committed to corporate social responsibility. Our sustainable packaging program is a testament to our proactive approach in managing our environmental impact and empowering our customers to meet their environmental goals. We will continue to collaborate with all our partners to improve our supply chain and create a sustainable future for all."

The new packaging has passed various tests, including low-temperature shipping tests between multiple continents ensuring that shipping quality and outcomes will remain high. The new packaging has received positive customer feedback during preliminary testing. GenScript has upgraded 80% of its shipping boxes, with plans to upgrade all types.

In 2023, GenScript joined the United Nations Global Compact (UNGC) and integrated the UNGC principles into our strategic planning. In 2024, we received a bronze rating from EcoVadis for our environmental, social and governance practices. We also joined the Science-Based Targets initiative (SBTi) and submitted our emissions reduction targets, expecting SBTi's validation this year. The packaging program is part of our initiatives to achieve our net zero ambition by 2050.

About GenScript Biotech Corporation

Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in healthcare and consumer goods by providing researchers and companies with the building blocks needed to develop groundbreaking treatments and products. Guided by its mission to Make People and Nature Healthier Through Biotechnology, and its role as a trusted global leader, GenScript has a team of over 5,000 employees and has served more than 200,000 customers across 100 countries.

Learn more here: https://www.genscript.com 

SOURCE GenScript Biotech Corporation


These press releases may also interest you

at 03:33
On March 12, the authoritative market research firm iResearch released a report named 2024 Consumer AR Glasses Market Dynamics and Industry Trend Insights, providing a comprehensive analysis of the development status, technological evolution, and...

at 03:31
The HERO ESPORTS Asian Champions League (ACL), Asia's premier multi-title esports tournament, hosted by leading esports company Hero Esports, officially launched on Wednesday in Shanghai, unveiling all nine game titles for its inaugural edition this...

at 03:28
Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion"; 1157.HK), a global leader in construction machinery, is bringing 67 premium construction machinery equipment to the bauma 2025 trade fair, the world's most influential construction...

at 03:26
Aquaporin A/S ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, today announces the Annual Report for the period January 1 to December 31, 2024. "Notwithstanding the...

at 03:20
LUND, SE / ACCESS Newswire / March 20, 2025 / BioInvent International AB ("BioInvent") , a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today...

at 03:20
TURKU, FI / ACCESS Newswire / March 20, 2025 / Faron Pharmaceuticals (HEL:FARON)(AIM:FARN) Shareholders' Nomination Board updates its recommendation on the number of Board members to be elected and the persons proposed to be electedFaron...



News published on and distributed by: